Newsletter | March 13, 2024

03.13.24 -- mRNA Meets Violin Making: What Can We Learn From Violin Makers?

FEATURED EDITORIAL

Violin Making Meets mRNA | ARW On RNA Ep03

Hosted by Advancing RNA's Anna Rose Welch, ARW on RNA puts a creative spin on the emerging mRNA + RNA therapeutics industry. Here, in Episode 3, Welch explores the similarities that exist between the art of crafting a high-quality violin and the upstream process development work mRNA therapeutics experts are performing today to create the most ideal mRNA drug substance.

Risk And Supply Chain Continuity Management: Biologics Industry Perspectives

We spoke to three long-standing members of BioPhorum’s Risk and Business Continuity Workstream about their companies’ approaches to risk management, supply chain continuity, and what they learned from the pandemic. Among them are Melinda McCants, senior resiliency officer at Amgen.

The Promise Of Genome Editing

Explore the evolution of genome editing, its present state, and its undeniable potential. Listen now to the details of Caribou Biosciences' chRDNA genome editing technology and how it differs from CRISPR-Cas9.

Understanding And Navigating Diverse Regulatory Environments

Drug developers aspire to treat patients globally, but navigating diverse regulatory structures around the world gets tricky. These consultants offer a primer on the regulatory bodies of the world.

INDUSTRY INSIGHTS

Trends In Next-Generation Delivery Technologies

Learn how lipid nanoparticles are enabling a new generation of engineered cell therapies with a push toward more complex cell engineering and gene editing for allogeneic therapies.

Key Challenges For CRISPR In Clinical Development

What is the best approach to CRISPR cell and gene therapy development challenges such as regulatory hurdles, ensuring consistency, finding experienced staff, and obtaining GMP-compliant reagents?

Scalable Purification Of In Vitro Transcribed mRNA

Learn about the isolation and purification benefits of a resin that is particularly useful in the manufacturing of in vitro transcribed mRNA.

Streamline Process Characterization For Successful Validation Campaigns

Explore how a stepwise approach for process characterization can help target the right experimental design and be tailored for different programs based on prior knowledge and experience.

Single-Use Technology For Quality mRNA Manufacturing

How do single-use technologies deliver important benefits for mRNA manufacturing, including increased speed, quality, flexibility, and adaptability to different dosages and scale-up strategies?

How mRNA Manufacturers Disrupt The Industry

Learn how biopharmaceutical companies can apply proven strategies to overcome hidden complexities in mRNA production, and discover solutions that can help you rapidly design and build a SU facility.